Publication Information

{'id': 'https://openalex.org/W2030957604', 'doi': 'https://doi.org/10.1158/1538-7445.am10-3514', 'title': 'Abstract 3514: LT-00673, a highly potent PARP inhibitor, shows antitumor activity against tumor cells with DNA repair deficiencies', 'display_name': 'Abstract 3514: LT-00673, a highly potent PARP inhibitor, shows antitumor activity against tumor cells with DNA repair deficiencies', 'publication_year': 2010, 'publication_date': '2010-04-01', 'ids': {'openalex': 'https://openalex.org/W2030957604', 'doi': 'https://doi.org/10.1158/1538-7445.am10-3514', 'mag': '2030957604'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am10-3514', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5111700905', 'display_name': 'Yuqiao Shen', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Yuqiao Jerry Shen', 'raw_affiliation_strings': ['1LEAD Therapeutics, Inc., San Bruno, CA.'], 'affiliations': [{'raw_affiliation_string': '1LEAD Therapeutics, Inc., San Bruno, CA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101904572', 'display_name': 'Ying Feng', 'orcid': 'https://orcid.org/0000-0003-0734-4060'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Ying Feng', 'raw_affiliation_strings': ['1LEAD Therapeutics, Inc., San Bruno, CA.'], 'affiliations': [{'raw_affiliation_string': '1LEAD Therapeutics, Inc., San Bruno, CA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100382530', 'display_name': 'Bing Wang', 'orcid': 'https://orcid.org/0000-0002-9038-9878'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Bing Wang', 'raw_affiliation_strings': ['1LEAD Therapeutics, Inc., San Bruno, CA.'], 'affiliations': [{'raw_affiliation_string': '1LEAD Therapeutics, Inc., San Bruno, CA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007496092', 'display_name': 'Daniel I. Chu', 'orcid': 'https://orcid.org/0000-0002-8835-6508'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Daniel Chu', 'raw_affiliation_strings': ['1LEAD Therapeutics, Inc., San Bruno, CA.'], 'affiliations': [{'raw_affiliation_string': '1LEAD Therapeutics, Inc., San Bruno, CA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109073348', 'display_name': 'Peter L. Myers', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Peter Myers', 'raw_affiliation_strings': ['1LEAD Therapeutics, Inc., San Bruno, CA.'], 'affiliations': [{'raw_affiliation_string': '1LEAD Therapeutics, Inc., San Bruno, CA.', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5085037854', 'display_name': 'Leonard Post', 'orcid': 'https://orcid.org/0009-0007-5779-4146'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Leonard Post', 'raw_affiliation_strings': ['1LEAD Therapeutics, Inc., San Bruno, CA.'], 'affiliations': [{'raw_affiliation_string': '1LEAD Therapeutics, Inc., San Bruno, CA.', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 64}, 'biblio': {'volume': '70', 'issue': '8_Supplement', 'first_page': '3514', 'last_page': '3514'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9977, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9977, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/parp-inhibitor', 'display_name': 'PARP inhibitor', 'score': 0.7431163}, {'id': 'https://openalex.org/keywords/synthetic-lethality', 'display_name': 'Synthetic Lethality', 'score': 0.46877638}], 'concepts': [{'id': 'https://openalex.org/C2779138821', 'wikidata': 'https://www.wikidata.org/wiki/Q7118227', 'display_name': 'PARP inhibitor', 'level': 5, 'score': 0.7431163}, {'id': 'https://openalex.org/C182979987', 'wikidata': 'https://www.wikidata.org/wiki/Q3907241', 'display_name': 'Poly ADP ribose polymerase', 'level': 4, 'score': 0.67866373}, {'id': 'https://openalex.org/C109316439', 'wikidata': 'https://www.wikidata.org/wiki/Q246181', 'display_name': 'Cytotoxicity', 'level': 3, 'score': 0.6604297}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.6056492}, {'id': 'https://openalex.org/C134935766', 'wikidata': 'https://www.wikidata.org/wiki/Q210538', 'display_name': 'DNA repair', 'level': 3, 'score': 0.5813774}, {'id': 'https://openalex.org/C143425029', 'wikidata': 'https://www.wikidata.org/wiki/Q5205747', 'display_name': 'DNA damage', 'level': 3, 'score': 0.50738543}, {'id': 'https://openalex.org/C2778502085', 'wikidata': 'https://www.wikidata.org/wiki/Q7662767', 'display_name': 'Synthetic lethality', 'level': 4, 'score': 0.46877638}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.45908988}, {'id': 'https://openalex.org/C154317977', 'wikidata': 'https://www.wikidata.org/wiki/Q376266', 'display_name': 'Cytotoxic T cell', 'level': 3, 'score': 0.44973317}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.44295228}, {'id': 'https://openalex.org/C96232424', 'wikidata': 'https://www.wikidata.org/wiki/Q4118072', 'display_name': 'Cancer cell', 'level': 3, 'score': 0.44122928}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.3864172}, {'id': 'https://openalex.org/C153911025', 'wikidata': 'https://www.wikidata.org/wiki/Q7202', 'display_name': 'Molecular biology', 'level': 1, 'score': 0.33481115}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.33331692}, {'id': 'https://openalex.org/C552990157', 'wikidata': 'https://www.wikidata.org/wiki/Q7430', 'display_name': 'DNA', 'level': 2, 'score': 0.30994207}, {'id': 'https://openalex.org/C82381507', 'wikidata': 'https://www.wikidata.org/wiki/Q416878', 'display_name': 'Polymerase', 'level': 3, 'score': 0.30247116}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.22148305}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.20066196}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.12524864}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am10-3514', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.79}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4309859277', 'https://openalex.org/W4229451438', 'https://openalex.org/W2808928250', 'https://openalex.org/W2747908831', 'https://openalex.org/W2614456022', 'https://openalex.org/W2548423821', 'https://openalex.org/W2140029877', 'https://openalex.org/W2105589846', 'https://openalex.org/W1985047304', 'https://openalex.org/W1645329610'], 'abstract_inverted_index': {'Abstract': [0], 'Poly': [1], '(ADP-ribose)': [2, 139], 'polymerases': [3], '(PARP)': [4], '−1': [5], 'and': [6, 18, 39, 93, 153, 155, 162, 222, 224], '−2': [7, 40], 'are': [8, 13, 71, 248], 'key': [9], 'nuclear': [10], 'enzymes': [11], 'that': [12, 35, 70, 84, 118, 241], 'activated': [14], 'by': [15, 50], 'DNA': [16, 27, 47, 56, 96], 'damage': [17], 'play': [19], 'a': [20, 112, 129, 185, 254], 'critical': [21], 'role': [22], 'in': [23, 73, 160, 184, 199, 202, 220], 'the': [24, 43, 178, 203, 209, 215, 266, 271], 'base': [25], 'excision': [26], 'repair': [28], '(BER)': [29], 'pathway.': [30], 'Previous': [31], 'studies': [32], 'have': [33, 62, 109], 'indicated': [34], 'inhibitors': [36, 61], 'of': [37, 46, 95, 105, 123, 132, 174, 181, 193, 218, 228, 232, 265, 270], 'PARP-1': [38, 120], 'could': [41], 'enhance': [42], 'tumor': [44, 168, 200, 236], 'cytotoxicity': [45, 104, 159], 'damaging': [48], 'agents': [49, 149], 'preventing': [51], 'cancer': [52, 68, 245], 'cells': [53, 69, 102], 'from': [54], 'repairing': [55], 'damage.': [57], 'In': [58, 142, 166, 208], 'addition,': [59], 'PARP': [60, 106, 114], 'been': [63], 'shown': [64], 'to': [65, 103, 251], 'selectively': [66], 'kill': [67], 'deficient': [72], 'BRCA-1': [74, 161], 'or': [75], 'BRCA-2': [76, 163], 'function.': [77], 'More': [78], 'recently,': [79], 'it': [80], 'was': [81], 'further': [82, 213], 'suggested': [83], 'other': [85], 'genetic': [86], 'deficiencies,': [87], 'such': [88, 150], 'as': [89, 151, 253], 'PTEN': [90], 'gene': [91], 'mutation': [92], 'malfunction': [94], 'mismatch': [97], 'repair,': [98], 'may': [99], 'also': [100, 128, 239], 'sensitize': [101], 'inhibitors.': [107], 'We': [108, 238], 'previously': [110], 'reported': [111], 'novel': [113], 'inhibitor,': [115], 'called': [116], 'LT-00673,': [117], 'inhibits': [119], 'with': [121], 'IC50': [122], '0.58': [124], 'nM.': [125], 'LT-00673': [126, 146, 175, 194, 219, 233, 252], 'is': [127], 'potent': [130, 157], 'inhibitor': [131], 'PARP-2,': [133], 'but': [134], 'does': [135], 'not': [136], 'inhibit': [137], 'poly': [138], 'glycohydrolase': [140], '(PARG).': [141], 'cell': [143, 246], 'culture': [144], 'studies,': [145, 170], 'potentiates': [147], 'chemotherapeutic': [148], 'temozolomide': [152], 'SN-38,': [154], 'displays': [156], 'single-agent': [158], 'mutant': [164], 'cells.': [165], 'xenograft': [167, 235], 'model': [169, 205], 'daily': [171, 190], 'oral': [172, 191], 'dosing': [173, 192, 230], 'significantly': [176], 'enhances': [177], 'antitumor': [179, 226], 'effects': [180], 'cytotoxic': [182], 'therapies': [183], 'dose-dependent': [186], 'manner.': [187], 'Furthermore,': [188], 'once': [189], 'at': [195], '0.33': [196], 'mg/kg/day': [197], 'results': [198], 'regression': [201], 'MX-1': [204], '(BRCA-1': [206], 'deficient).': [207], 'current': [210], 'study,': [211], 'we': [212], 'investigated': [214], 'pharmacokinetic': [216], 'properties': [217], 'dogs': [221], 'rats,': [223], 'compared': [225], 'efficacies': [227], 'different': [229], 'schedules': [231], 'using': [234], 'models.': [237], 'demonstrated': [240], 'several': [242], 'PTEN-deficient': [243], 'human': [244], 'lines': [247], 'highly': [249], 'sensitive': [250], 'single': [255], 'agent.': [256], 'Citation': [257], 'Format:': [258], '{Authors}.': [259], '{Abstract': [260], 'title}': [261], '[abstract].': [262], 'In:': [263], 'Proceedings': [264], '101st': [267], 'Annual': [268], 'Meeting': [269], 'American': [272], 'Association': [273], 'for': [274], 'Cancer': [275, 285], 'Research;': [276], '2010': [277], 'Apr': [278], '17-21;': [279], 'Washington,': [280], 'DC.': [281], 'Philadelphia': [282], '(PA):': [283], 'AACR;': [284], 'Res': [286], '2010;70(8': [287], 'Suppl):Abstract': [288], 'nr': [289], '3514.': [290]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2030957604', 'counts_by_year': [], 'updated_date': '2024-12-08T12:33:04.315000', 'created_date': '2016-06-24'}